{"id":"W4399361514","doi":"10.1016/j.esmoop.2024.103466","title":"Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Astellas Pharma; Chugai Pharmaceutical; Seagen; Gilead Sciences; Eisai; Daiichi Sankyo Europe; Sanofi; Novartis; Daiichi-Sankyo; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Palbociclib; Hormone receptor; Docetaxel; Gynecology; Chemotherapy; Cancer; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001124434,0.0004971743,0.0009285636,0.0002758684,0.0000460189,0.00005334048,0.0002222726,0.00007321875,0.0005695913],"category_scores_gemma":[0.0000121755,0.0003228139,0.0000552069,0.0008894688,0.000194982,0.0005534291,0.0001079829,0.00029356,0.00001055701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001016192,"about_ca_system_score_gemma":0.0002707159,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06031082,"about_ca_topic_score_gemma":0.01569804,"domain_scores_codex":[0.9975926,0.0001686828,0.0005526677,0.0007367677,0.0004845829,0.0004646837],"domain_scores_gemma":[0.9988201,0.00011052,0.0002548128,0.0004079131,0.000263512,0.0001431904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05374476,0.002419385,0.9179515,0.00007060065,0.000996154,0.0001174192,0.002993767,0.000104589,0.000211831,0.00001114315,0.00004497852,0.02133391],"study_design_scores_gemma":[0.03048907,0.006710366,0.9535511,0.001477275,0.0002352724,0.000005431619,0.000190313,0.00002371191,0.006715605,0.0000541882,0.000180576,0.0003671447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949076,0.0003192537,0.0000156244,0.0005273963,0.00007793376,0.003077234,0.0008431628,0.00003967306,0.0001920842],"genre_scores_gemma":[0.9959223,0.0004985199,0.001504236,0.0001280497,0.00003952597,0.001042355,0.0003218062,0.0001142005,0.000429004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04461278,"threshold_uncertainty_score":0.9999224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009595296794721674,"score_gpt":0.2882959797367978,"score_spread":0.2787006829420762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}